Moreover, similar results were observed in COVID-19 non-survivors, and increased expression of PD-1 combined with increased expression of CD38 on CD3+CD8+ T cells was shown to be a risk factor for unfavourable outcomes in patients with COVID-19 [26]. Here, PDCD1 is linked to COVID-19.